Cross-sectional Evaluation of Mycobacterial Associations with Lung Disease and Its Associated Factors

Authors

  • Mehvish Aqil DHQ Hospital /Allied Hospital 2, Faisalabad,Pakistan. https://orcid.org/0009-0003-4235-9978
  • Malik Istikhar Ali Sajjad Allied Hospital 2 Faisalabad Medical University, Faisalabad ,Pakistan.
  • Mehr Muhammad Imran Allied Hospital 1 Faisalabad ,Pakistan.
  • Sarah Akram Allied Hospital 2 Faisalabad Medical University, Faisalabad ,Pakistan.
  • Noor Gul Allied Hospital Faisalabad Medical University Faisalabad ,Pakistan.
  • Usman Khalid DHQ Hospital /Allied Hospital 2, Faisalabad,Pakistan.

DOI:

https://doi.org/10.36283/ziun-pjmd14-3/018

Keywords:

Nontuberculous Mycobacteria, Mycobacterium Tuberculosis, Bronchiectasis, Chronic Cough, Sputum , Epidemiology

Abstract

Background: Nontuberculous mycobacteria (NTM), a diverse group of environmental organisms rapidly proliferating in water, soil, and dust, are becoming a common cause of clinical disease. This study analyzed patient data from two major hospitals in Faisalabad, Pakistan, to improve early detection of NTM lung disease and to guide clinical practice in seeking earlier and quicker intervention.  

Methods: A retrospective cross-sectional study was conducted from January 2020 to December 2021, using the records of 294 tuberculosis patients at Allied Hospital and DHQ Hospital, Faisalabad. Non-probability convenience sampling was used for sample collection and sample size was collected using OpenEpi 3.0.0.  Data from patients with NTM lung disease were checked. The diagnosis was based on criteria defined by the ATS/IDSA (a clinical, radiological and microbiological evidence). Testing of specimens (sputum, BAL fluid, puncture fluid) was conducted using AFB smear, culture (MGIT 960) and species identification by molecular techniques. Chi-square, Wilcoxon tests and logistic regression were performed using SPSS version 26.0.p<0.05 was considered as significant.

Results: There were 294 patients (147 males; 147 females); median age 61 years, 77.2% had bronchiectasis. The most frequently identified species was the Mycobacterium avium-intracellulare complex (MAC 56.1%) followed by M. kansasii (19%) and M. abscessus (15.3%).   Sputum cultures had the highest positivity rate (87.4%), outperforming BAL fluid (80.3%) and puncture fluid (61.5%).

Conclusion: The M. avium-intracellulare complex is the most common NTM species found in patients in these hospitals. The signs of expectoration, gender and bronchiectasis increased likelihood of BAL culture positivity, which aids in diagnosis.

Author Biographies

  • Mehvish Aqil, DHQ Hospital /Allied Hospital 2, Faisalabad,Pakistan.

    Department of Pulmonology, 

  • Malik Istikhar Ali Sajjad , Allied Hospital 2 Faisalabad Medical University, Faisalabad ,Pakistan.

    Department of Pulmonology,

  • Mehr Muhammad Imran , Allied Hospital 1 Faisalabad ,Pakistan.

    Department of Pulmonology,

  • Sarah Akram , Allied Hospital 2 Faisalabad Medical University, Faisalabad ,Pakistan.

    Department of Pulmonology,

  • Noor Gul , Allied Hospital Faisalabad Medical University Faisalabad ,Pakistan.

    Department of Pulmonology,

  • Usman Khalid , DHQ Hospital /Allied Hospital 2, Faisalabad,Pakistan.

    Department of Pulmonology,

References

1. Zhang L, Lin TY, Liu WT, Ling F. Toward Characterizing Environmental Sources of Non-tuberculous Mycobacteria (NTM) at the Species Level: A Tutorial Review of NTM Phylogeny and Phylogenetic Classification. ACS Environ Au. 2024 Feb 23;4(3):127-141. doi: 10.1021/acsenvironau.3c00074.

2. Marty PK, Yetmar ZA, Gerberi DJ, Escalante P, Pennington KM, Mahmood M. Risk factors and outcomes of non-tuberculous mycobacteria infection in lung transplant recipients: A systematic review and meta-analysis. J Heart Lung Transplant. 2023 Feb;42(2):264-274. doi: 10.1016/j.healun.2022.10.004.

3. Bhanushali J, Jadhav U, Ghewade B, Wagh P. Unveiling the Clinical Diversity in Nontuberculous Mycobacteria (NTM) Infections: A Comprehensive Review. Cureus. 2023 Nov 4;15(11):e48270. doi: 10.7759/cureus.48270.

4. Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, Abd El Aziz MS, et al. Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol. 2024 Oct;22(10):617-635. doi: 10.1038/s41579-024-01025-1.

5. Youssefnia A, Pierre A, Hoder JM, MacDonald M, Shaffer MJB, Friedman J, et al. Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review. J Thorac Dis. 2022 Sep;14(9):3575-3597. doi: 10.21037/jtd-22-410.

6. Cheng LP, Chen SH, Lou H, Gui XW, Shen XN, Cao J, et al. Factors Associated with Treatment Outcome in Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Large Population-Based Retrospective Cohort Study in Shanghai. Trop Med Infect Dis. 2022 Feb 15;7(2):27. doi: 10.3390/tropicalmed7020027.

7. Dong B, He Z, Li Y, Xu X, Wang C, Zeng J. Improved Conventional and New Approaches in the Diagnosis of Tuberculosis. Front Microbiol. 2022 May 31;13:924410. doi: 10.3389/fmicb.2022.924410.

8. Sharma SK, Upadhyay V, Mohan A. What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? Indian J Med Res. 2021 Mar;154(3):405-409. doi: 10.4103/ijmr.ijmr_2573_21.

9. Ku JH, Henkle E, Carlson KF, Marino M, Brode SK, Marras TK, et al. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Clin Infect Dis. 2023 Feb 8;76(3):e1408-e1415. doi: 10.1093/cid/ciac394.

10. Bhardwaj R, Agrawal U, Vashist P, Manna S. Determination of sample size for various study designs in medical research: A practical primer. J Family Med Prim Care. 2024 Jul;13(7):2555-2561. doi: 10.4103/jfmpc.jfmpc_1675_23.

11. van Ingen J, Obradovic M, Hassan M, Lesher B, Hart E, Chatterjee A, et al. Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments. Expert Rev Respir Med. 2021 Nov;15(11):1387-1401. doi: 10.1080/17476348.2021.1987891.

12. Suska K, Amati F, Sotgiu G, Gramegna A, Mantero M, Ori M, et al. Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis. ERJ Open Res. 2022 Dec 12;8(4):00060-2022. doi: 10.1183/23120541.00060-2022.

13. Solarat B, Perea L, Faner R, de La Rosa D, Martínez-García MÁ, Sibila O. Pathophysiology of Chronic Bronchial Infection in Bronchiectasis. Arch Bronconeumol. 2023 Feb;59(2):101-108. English, Spanish. doi: 10.1016/j.arbres.2022.09.004.

14. Elbrolosy AM, El Helbawy RH, Mansour OM, Latif RA. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis. BMC Microbiol. 2021 May 13;21(1):144. doi: 10.1186/s12866-021-02210-5.

15. Chindam A, Vengaldas S, Srigiri VR, Syed U, Kilaru H, Chenimilla NP, et al. Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case series. J Clin Tuberc Other Mycobact Dis. 2021 Aug 30;25:100271. doi: 10.1016/j.jctube.2021.100271.

16. Dhasmana DJ, Whitaker P, van der Laan R, Frost F. A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom. NPJ Prim Care Respir Med. 2024 Dec 21;34(1):45. doi: 10.1038/s41533-024-00403-9.

17. Hull RC, Huang JTJ, Barton AK, Keir HR, Ellis H, Cookson WOC, et al. Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease. Chest. 2022 May;161(5):1180-1191. doi: 10.1016/j.chest.2021.11.014.

18. Reich JM. Pathogenesis of Lady Windermere syndrome. Scand J Infect Dis. 2012 Jan;44(1):1-2. doi: 10.3109/00365548.2011.603746.

19. Rao R, Sheshadri S, Patil N, Rao K, Arivazhahan A. Lady Windermere Syndrome: A Very Rare Entity In Indian Medical Scenario. J Clin Diagn Res. 2016 Jan;10(1):OD01-2. doi: 10.7860/JCDR/2016/17540.7024.

20. Matsuyama M, Matsumura S, Nonaka M, Nakajima M, Sakai C, Arai N, et al. Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease. Respir Investig. 2023 Mar;61(2):135-148. doi: 10.1016/j.resinv.2022.12.002.

21. Gupta M, Srikrishna G, Klein SL, Bishai WR. Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Trends Immunol. 2022 Aug;43(8):640-656. doi: 10.1016/j.it.2022.06.004.

22. Hendrix C, McCrary M, Hou R, Abate G. Diagnosis and Management of Pulmonary NTM with a Focus on Mycobacterium avium Complex and Mycobacterium abscessus: Challenges and Prospects. Microorganisms. 2022 Dec 23;11(1):47. doi: 10.3390/microorganisms11010047.

23. Lee JH, Garg T, Lee J, McGrath S, Rosman L, Schumacher SG, et al. Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2022 Dec 14;22(1):940. doi: 10.1186/s12879-022-07855-9.

24. Parsons LM, Somoskövi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev. 2011 Apr;24(2):314-50. doi: 10.1128/CMR.00059-10.

25. Maya TG, Komba EV, Mensah GI, Mbelele PM, Mpagama SG, Mfinanga SG, et al. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania. PLoS One. 2022 Mar 24;17(3):e0265358. doi: 10.1371/journal.pone.0265358.

Downloads

Published

2025-07-21

Metrics

How to Cite

1.
Aqil M, Sajjad MIA, Imran MM, Akram S, Gul N, Khalid U. Cross-sectional Evaluation of Mycobacterial Associations with Lung Disease and Its Associated Factors. PJMD [Internet]. 2025 Jul. 21 [cited 2026 Jun. 4];14(3):115-20. Available from: https://ojs.zu.edu.pk/pjmd/article/view/3879

Similar Articles

81-90 of 130

You may also start an advanced similarity search for this article.